# ‚öîÔ∏è AYESHA PLANS & DOCTRINES MASTER DOCUMENT ‚öîÔ∏è

**Date**: January 13, 2025  
**Status**: ‚úÖ **CONSOLIDATED SOURCE OF TRUTH**  
**Consolidated From**:
- `AYESHA_END_TO_END_AGENT_PLAN.mdc` - End-to-end agent execution plan
- `AyeshasGenetics.mdc` - Ayesha's genetics documentation
- `AyeshasGenetics copy.mdc` - Duplicate (archived)
- `SAE_COMPLETION_ROADMAP.mdc` - SAE completion roadmap
- `TreatmentLine-Blog.mdc` - Treatment line blog content
- `ayesha_plan.mdc` - Main Ayesha plan
- `sporadic_cancer_strategy_doctrine.mdc` - Sporadic cancer strategy doctrine
- `SPORADIC_CANCER_EXECUTION_PLAN.md` - Complete sporadic cancer execution plan
- `SPORADIC_FINAL_STATUS.md` - Sporadic cancer implementation status
- `ADVANCED_CARE_PLAN_EXPLAINED.md` - Plain-language care plan explanation

---

## üìö TABLE OF CONTENTS

1. [Executive Summary](#executive-summary)
2. [End-to-End Agent Plan](#end-to-end-agent-plan)
3. [Ayesha's Genetics](#ayeshas-genetics)
4. [SAE Completion Roadmap](#sae-completion-roadmap)
5. [Treatment Line Blog](#treatment-line-blog)
6. [Main Ayesha Plan](#main-ayesha-plan)
7. [Sporadic Cancer Strategy Doctrine](#sporadic-cancer-strategy-doctrine)
8. [References to Archived Files](#references-to-archived-files)

---

## üéØ EXECUTIVE SUMMARY

This master document consolidates all Ayesha-related plans, doctrines, and strategic documents. These files contain the complete execution strategy, genetic information, and roadmap for Ayesha's precision oncology care.

**Key Documents**:
- **End-to-End Agent Plan**: Complete execution plan for Ayesha's care
- **Main Ayesha Plan**: Primary strategic plan document
- **Sporadic Cancer Strategy Doctrine**: Complete doctrine for sporadic cancer approach
- **SAE Completion Roadmap**: Roadmap for SAE feature completion
- **Treatment Line Blog**: Blog content about treatment lines
- **Ayesha's Genetics**: Genetic information and analysis

---

## üìã END-TO-END AGENT PLAN

**File**: `AYESHA_END_TO_END_AGENT_PLAN.mdc`

**Status**: ‚öîÔ∏è **MASTER PLAN** - Single source of truth for Ayesha execution

**Content**: Complete end-to-end execution plan for Ayesha's precision oncology care, including all agent assignments, timelines, and deliverables.

**Full Content**: See archived `archive/AYESHA_END_TO_END_AGENT_PLAN.mdc`

---

## üß¨ AYESHA'S GENETICS

**File**: `AyeshasGenetics.mdc`

**Status**: ‚úÖ **ACTIVE** - Genetic information for Ayesha

**Content**: Complete genetic analysis, variant information, and genomic context for Ayesha's case.

**Full Content**: See archived `archive/AyeshasGenetics.mdc`

**Note**: `AyeshasGenetics copy.mdc` is a duplicate and has been archived.

---

## üó∫Ô∏è SAE COMPLETION ROADMAP

**File**: `SAE_COMPLETION_ROADMAP.mdc`

**Status**: ‚è∏Ô∏è **ROADMAP** - SAE feature completion plan

**Content**: Roadmap for completing Sparse Autoencoder (SAE) features and integration.

**Full Content**: See archived `archive/SAE_COMPLETION_ROADMAP.mdc`

---

## üìù TREATMENT LINE BLOG

**File**: `TreatmentLine-Blog.mdc`

**Status**: ‚úÖ **BLOG CONTENT** - Treatment line educational content

**Content**: Blog content explaining treatment lines in oncology and their significance.

**Full Content**: See archived `archive/TreatmentLine-Blog.mdc`

---

## üéØ MAIN AYESHA PLAN

**File**: `ayesha_plan.mdc`

**Status**: ‚öîÔ∏è **PRIMARY PLAN** - Main strategic plan document

**Content**: Primary strategic plan for Ayesha's precision oncology care, including all phases, milestones, and success criteria.

**Full Content**: See archived `archive/ayesha_plan.mdc`

---

## üèõÔ∏è SPORADIC CANCER STRATEGY DOCTRINE

**File**: `sporadic_cancer_strategy_doctrine.mdc`

**Status**: ‚öîÔ∏è **ACTIVE DOCTRINE** - Complete sporadic cancer strategy

**Content**: Complete doctrine for managing sporadic (non-hereditary) cancer cases, including tumor genomics, treatment line intelligence, and clinical trial matching.

**Full Content**: See archived `archive/sporadic_cancer_strategy_doctrine.mdc`

**Note**: This doctrine is also referenced in `.cursor/rules/specialized_systems/archive/sporadic_cancer_strategy_doctrine.mdc`

---

## ‚öîÔ∏è SPORADIC CANCER EXECUTION PLAN

**File**: `SPORADIC_CANCER_EXECUTION_PLAN.md`

**Status**: ‚úÖ **85% COMPLETE** - Backend + Frontend + Validation complete

**Content**: Complete execution plan for sporadic cancer workflow implementation, including:
- Day 1: Backend foundation (TumorContext schema, Quick Intake router/service)
- Day 2: Efficacy gates (PARP penalty, IO boost, confidence capping)
- Day 4-5: Frontend UX (9 components, 1,400+ lines React/MUI)
- Agent Jr Missions: Disease priors (15 cancers), validation testing (25 scenarios)

**Key Features**:
- **PARP Penalty**: Germline-negative ‚Üí 0.6x (unless HRD ‚â•42 ‚Üí RESCUE!)
- **IO Boost**: TMB ‚â•20 ‚Üí 1.35x, MSI-H ‚Üí 1.30x
- **Confidence Cap**: L0 ‚Üí 0.4, L1 ‚Üí 0.6, L2 ‚Üí none
- **Test Coverage**: 33/33 tests passing (100%)

**Full Content**: See `SPORADIC_CANCER_EXECUTION_PLAN.md` (1,439 lines)

---

## üìä SPORADIC CANCER FINAL STATUS

**File**: `SPORADIC_FINAL_STATUS.md`

**Status**: ‚úÖ **DAYS 1-5 COMPLETE**

**Deliverables**:
- Backend: ~2,400 lines Python, 2 endpoints, 100% test pass rate
- Frontend: ~1,400 lines React/MUI, 9 components, complete routing
- Data: 15 cancers supported, 25 test scenarios validated
- Documentation: ~5,000 lines

**Current State**: 85% complete - WIWFM integration pending (Agent Jr Mission 4)

**Full Content**: See `SPORADIC_FINAL_STATUS.md`

---

## üéØ ADVANCED CARE PLAN EXPLANATION

**File**: `ADVANCED_CARE_PLAN_EXPLAINED.md`

**Status**: ‚úÖ **ACTIVE** - Plain-language explanation

**Content**: Complete explanation of advanced care plan features in plain language, including:
- Targeted combination strategies (PARP + ATR, PARP + Bevacizumab, etc.)
- Resistance playbook (predicts resistance mechanisms and backup plans)
- Toxicity risk assessment (germline pharmacogene variants)
- Treatment line intelligence (when to switch, what to monitor)
- Adaptive care planning (generates new plans when cancer evolves)

**Full Content**: See `ADVANCED_CARE_PLAN_EXPLAINED.md` (606 lines)

---

## üìñ REFERENCES TO ARCHIVED FILES

All original files have been preserved in `.cursor/ayesha/archive/`:

- **End-to-End Agent Plan**: `archive/AYESHA_END_TO_END_AGENT_PLAN.mdc`
- **Ayesha's Genetics**: `archive/AyeshasGenetics.mdc`
- **Ayesha's Genetics (Duplicate)**: `archive/AyeshasGenetics copy.mdc`
- **SAE Completion Roadmap**: `archive/SAE_COMPLETION_ROADMAP.mdc`
- **Treatment Line Blog**: `archive/TreatmentLine-Blog.mdc`
- **Main Ayesha Plan**: `archive/ayesha_plan.mdc`
- **Sporadic Cancer Strategy Doctrine**: `archive/sporadic_cancer_strategy_doctrine.mdc`

---

## ‚öîÔ∏è DOCTRINE STATUS: ACTIVE

**LAST UPDATED:** January 13, 2025  
**APPLIES TO:** All Ayesha plans, doctrines, and strategic documents  
**ENFORCEMENT:** Mandatory across all Ayesha-related development and execution

**This master document represents the complete consolidation of all Ayesha plans and doctrines. Every plan, roadmap, and strategic document is preserved and organized for maximum clarity and actionability.**
